Abstract:OBJECTIVE:To explore the involvement of intron A into eukaryotic expression vector to improve antigen expression efficiency and enhance immunogenicity of DNA vaccine in mice.METHODS:As model antigen, the coding gene of mycobacterial Hsp65 was cloned into eukaryotic expression vector pCMV4.0 with intron A involved and pVAX1 without intron A involved, respectively. The resulted recombinant expression vectors were transfected into 293T cells and were then injected into BALB/c mice as DNA vaccines. Anti-Hsp65 specific IgG and isotype were detected by ELISA and T cell immune response was analyzed by enzyme-linked immunosorbent spot (ELISPOT) assay and intracellular cytokine staining.RESULTS:Compared with non-intron A pVAX1hsp65, the recombinant plasmid pCMV4.0hsp65 involved with intron A pVAX1hsp65 caused higher expression level of Hsp65 in 293T cells, and enhanced Th1 type immune response, which was defined as higher level of anti-Hsp65 specific total IgG level (3.76 ± 0.23 vs 3.15 ± 0.22, P < 0.01) and IgG2a/IgG1 ratio (4.08 ± 0.04 vs 2.23 ± 0.12, P < 0.01) and more IFN-γ-secreting CD4(+) ((2.0 ± 0.058)% vs (1.5 ± 0.087)%, t = 4.804, P < 0.01) and CD8(+) ((0.6 ± 0.058)% vs (1.0 ± 0.115)%, t = 3.098, P < 0.05) T lymphocytes. The difference showed statistical significance.CONCLUSION:Intron A can improve the expression efficiency of mycobacterial Hsp65 antigen and enhance immunogenicity of DNA vaccine in mice when involved into eukaryotic expression vector.

Effct of Heat Shock Protein 65 of Mycobacterium Tuberculosis on Prevention of Diabetes in Nonobese Diabetic Mice

[Improved Efficacy of P277 Fused to Heat Shock Protein 65 of Mycobacterium Tuberculosis Against Diabetes in Nonobese Diabetic Mice].

[Intranasal Vaccination with Mycobacterial 65-Kd Heat-Shock Protein Can Prevent Insulitis and Diabetes in Non-Obese Diabetic Mice].

Purification and Stability Research of Mycobacterial Heat Shock Protein 65 and Its Fusion Protein Hsp65-6 P277

Intranasal Vaccination with P277 Tandem Repeat Sequences Carried by Hsp65 Prevented Type 1 Diabetes in NOD Mice

Study on the Hypoglycemic Mechanism of the Fusion Protein HSP65-6×P277 in NOD Mice

Protection Against Tuberculosis by Bone Marrow Cells Expressing Mycobacterial Hsp65.

Oral Administration of Recombinant Lactococcus Lactis Expressing Hsp65 and Tandemly Repeated P277 Reduces the Incidence of Type I Diabetes in Non-Obese Diabetic Mice

Oral Administration of Lactococcus Lactis-Expressing Heat Shock Protein 65 and Tandemly Repeated IA2P2 Prevents Type 1 Diabetes in NOD Mice.

A Single Mycobacterial Protein (hsp 65) Expressed by a Transgenic Antigen-Presenting Cell Vaccinates Mice Against Tuberculosis.

The Preparation of Mycobacterium Tuberculosis HSP65 DNA Vaccine and the Prokaryotic Expression of the Recombinant HSP65 Protein

Expression and Purification of Heat Shock Protein 65(HSP65) of Mycobacterium Leprae and Preparation of Anti-HSP65 Polyclonal Antiserum

Prevention of Strain Fermentation in Hirsutella Sinensis on Type 1 Diabetes of Non-Obese Diabetic Mice

Identification And Characterization Of Protective T Cells In Hsp65 Dna-Vaccinated And Mycobacterium Tuberculosis-Infected Mice

Administration of heat shock protein 65 inhibits murine melanoma growth in vivo.

A Heterologous DNA Priming-Mycobacterium Bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection Against Tuberculosis in Mice.

Enhanced Immunogenicity of Peptide P277 by Heat Shock Protein Hsp65 Vector Carrying Tandem Repeats of P277 to Prevent Type 1 Diabetes in Nod Mice

The Strengthening Effect to Subsequence Aggressive Immunization of Pre-Immunization with Mycobacterium Tuberculosis' Conservative B Cell Epitopes Via Membrana Mucosa Nasi

Involvement of Intron A into Eukaryotic Expression Vector to Improve Immunogenicity of Mycobacterial Heat-Shock Protein 65 DNA Vaccine in Mice

Oral administration of CTB insulin B chain produced in silkworm delays the diabetes development in NOD mice

Antitumor therapeutic effect induced by intestine- carcinoma cells vaccine expressing membrane- bound heat shock protein 70